Safety study of an oral drug in recent opioid users
Part of Mental health clinical trials.
This study tests an investigational oral medication called MG001 in healthy people who have recently used oral opioids. It aims to see how the drug affects your body and whether it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 18 and 65 years old
- Must have used oral opioids (prescription or recreational) at least once in the past 30 days
- Must not have used opioids intravenously or on 3 or more consecutive days in the past month
- Women must be unable to become pregnant (e.g., surgically sterile or past menopause)
- Must not have significant heart, liver, kidney, or psychiatric conditions
- Must be willing to avoid certain medications and supplements during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called VK4-116 in healthy volunteers to see how food affects its absorption in the body. Participation may help researchers understand how the drug works and could lead to new treatments for conditions like opioid use disorder, though you would not directly benefit.
This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.
This early study tests how kratom can change the body’s handling of oxycodone (a prescription opioid) and how safe and measurable the effects are. It may help researchers understand drug interactions, especially for people who have used kratom and opioids before.
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests how a new combination of oxycodone and nafamostat works in the body. It is for healthy volunteers aged 18 to 55 to help understand the drug's safety and how it is processed.
Hear when a new Safety and Tolerability in Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.